0
Skip to Content
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
Home
Folder: About
Back
About NMD Pharma
Management team
Our team
Board
Founders
Folder: R&D
Back
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
Folder: News
Back
Press releases
Events
Other news
Investors
Folder: Careers
Back
Your career
Find your job
Contact
We’re proud to share a special video marking NMD Pharma’s 10-year anniversary
Events Stine Krag Brunvold 5/29/25 Events Stine Krag Brunvold 5/29/25

We’re proud to share a special video marking NMD Pharma’s 10-year anniversary

Read More
NMD Pharma raises awareness ahead of Rare Disease Day, 2025
Events Stine Krag Brunvold 2/27/25 Events Stine Krag Brunvold 2/27/25

NMD Pharma raises awareness ahead of Rare Disease Day, 2025

Read More
ClC-1 inhibition for improvement of muscle function in CMT webinar
Events Stine Krag Brunvold 11/30/24 Events Stine Krag Brunvold 11/30/24

ClC-1 inhibition for improvement of muscle function in CMT webinar

Read More
Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma
Events Stine Krag Brunvold 4/25/24 Events Stine Krag Brunvold 4/25/24

Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma

Read More
NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine
Events Stine Krag Brunvold 3/21/24 Events Stine Krag Brunvold 3/21/24

NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine

Read More
Rare Disease Day, 28 February 2023
Events Stine Krag Brunvold 2/28/23 Events Stine Krag Brunvold 2/28/23

Rare Disease Day, 28 February 2023

Read More
Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis
Events Stine Krag Brunvold 10/11/22 Events Stine Krag Brunvold 10/11/22

Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis

Read More
NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1

Read More
NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2

Read More
NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3

Read More
NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A

Read More
An active future made possible by the power of science
Events Stine Krag Brunvold 7/7/22 Events Stine Krag Brunvold 7/7/22

An active future made possible by the power of science

Read More

NMD PHARMA A/S, CVR No. 36899069

Cookie Policy Terms of Use Privacy Policy US Expanded Access Policy

Follow us
LinkedIn and X